Tag archive for ‘Dr. Ariel Katz’
Gil Tanenbaum On Tuesday, September 16th, 2014

Class Action Suit Accusing Israeli Enzymotec of IPO Fraud

A federal securities class action suit has been filed against the Israeli company Enzymotec, which develops and manufactures nutritional ingredients and medical foods. The suit claims Enzymotec violated U.S. More...

Enzymotec Seeks $100 Million Nasdaq Exit

– Enzymotec Ltd. Files Registration Statement for Proposed Secondary Offering – –  Enzymotec Ltd. (Nasdaq:ENZY) today announced that it has filed a registration statement on Form F-1 with More...

Wordpress site Developed by Fixing WordPress Problems